NCT01925131 2023-05-03S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute LeukemiaSWOG Cancer Research NetworkPhase 1 Completed50 enrolled 14 charts
NCT00866307 2021-04-27Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)Children's Oncology GroupPhase 1 Completed104 enrolled 9 charts